Track topics on Twitter Track topics that are important to you
FRIDAY, Oct. 11, 2019 -- Ibrutinib is associated with an increased risk for new or worsened hypertension in patients treated for B-cell malignancies, according to a study published online Oct. 3 in Blood. Tyler Dickerson, Ph.D., from The Ohio State...
Original Article: Ibrutinib Therapy Linked to New, Worsened HypertensionNEXT ARTICLE
Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs of affected individuals. Symptoms can range from mild breathles...